Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies (DEE) are clinically and genetically heterogeneous severely devastating conditions. Recent studies emphasized de novo variants as major underlying cause suggesting a generally low-recurrence risk. In order to better understand the full genetic landscape of EE and DEE, we performed high-resolution chromosomal microarray analysis in combination with whole-exome sequencing in 63 deeply phenotyped independent patients. After bioinformatic filtering for rare variants, diagnostic yield was improved for recessive disorders by manual data curation as well as molecular modeling of missense variants and untargeted plasma-metabolomics in selected patien...
Epilepsy is the most common serious neurological disorder, and there is a genetic basis in almost 50...
Developmental and Epileptic encephalopathies (DEE) describe heterogeneous epilepsy syndromes, charac...
International audienceDevelopmental and epileptic encephalopathy (DEE) is a group of conditions char...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
Epileptic encephalopathies (EEs) are the most clinically important group of severe early-onset epile...
Epileptic encephalopathies (EEs) are the most clinically important group of severe early-onset epile...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
BACKGROUND: Many genes are candidates for involvement in epileptic encephalopathy (EE) because one o...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
PURPOSE: The management of epilepsy in children is particularly challenging when seizures are resist...
We investigated the genetic background of early-onset epileptic encephalopathy (EE) using targeted n...
<div><p>Trio exome sequencing has been successful in identifying genes with <i>de novo</i> mutations...
Epilepsy is the most common serious neurological disorder, and there is a genetic basis in almost 50...
Developmental and Epileptic encephalopathies (DEE) describe heterogeneous epilepsy syndromes, charac...
International audienceDevelopmental and epileptic encephalopathy (DEE) is a group of conditions char...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
Epileptic encephalopathies (EEs) are the most clinically important group of severe early-onset epile...
Epileptic encephalopathies (EEs) are the most clinically important group of severe early-onset epile...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
BACKGROUND: Many genes are candidates for involvement in epileptic encephalopathy (EE) because one o...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
PURPOSE: The management of epilepsy in children is particularly challenging when seizures are resist...
We investigated the genetic background of early-onset epileptic encephalopathy (EE) using targeted n...
<div><p>Trio exome sequencing has been successful in identifying genes with <i>de novo</i> mutations...
Epilepsy is the most common serious neurological disorder, and there is a genetic basis in almost 50...
Developmental and Epileptic encephalopathies (DEE) describe heterogeneous epilepsy syndromes, charac...
International audienceDevelopmental and epileptic encephalopathy (DEE) is a group of conditions char...